<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>SELECT Trial on GLP-1 Guide — Ozempic, Wegovy, Mounjaro</title><link>https://glp1decode.com/tags/select-trial/</link><description>Recent content in SELECT Trial on GLP-1 Guide — Ozempic, Wegovy, Mounjaro</description><image><title>GLP-1 Guide — Ozempic, Wegovy, Mounjaro</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>en</language><lastBuildDate>Tue, 16 Jun 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://glp1decode.com/tags/select-trial/index.xml" rel="self" type="application/rss+xml"/><item><title>GLP-1 Medications and Heart Health: What SELECT and Other Trials Reveal (2026)</title><link>https://glp1decode.com/posts/glp1-heart-health-cardiovascular-benefits-2026/</link><pubDate>Tue, 16 Jun 2026 00:00:00 +0000</pubDate><guid>https://glp1decode.com/posts/glp1-heart-health-cardiovascular-benefits-2026/</guid><description>Do GLP-1 medications protect your heart? A deep dive into the SELECT trial and other cardiovascular outcomes research — what semaglutide does for heart attack, stroke, and cardiovascular death risk in 2026.</description></item></channel></rss>